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Cinnamic acid and its derivatives are an important member of the phenolic compound used in food 
supplements. They usually occur in various conjugated forms, more frequently esters and glycosides. 
Mice (Mus musculus, 2n = 40) were employed as an experimental mammalian system to assess the 
anticlastogenic activity of cinnamic acid (CA) induced by Endoxan. Four doses; 1/32, 1/16, 1/8 and 1/4 of 
the LD50 of CA (5, 10, 20 and 40 mg/kg, respectively) in combination with five administration times of CA 
were tested. Micronucleated polychromatic erythrocytes (PCE) and mitotic index (MI) were used as a 
sensitive short term genotoxic bioassays. The results obtained showed that low doses (1/32 LD50 and 
1/16 LD50) decreased the percentage of PCE significantly compared with that of the positive control and 
closer to that of the negative control. The data of this study were used to calculate a new index called 
anticlastogenic index (ACI). The new index measures the anticlastogenic activity of a compound or an 
extract. The ACI beside the percentage of PCE can give a deeper look of the anticlastogenic activity of 
compounds. It also makes it easy to draw conclusions from the genotoxicity data. The maximum ACI of 
CA was achieved when both CA and Endoxan were given concurrently. On the other hand, the higher 
doses of CA (1/8 and 1/4 LD50) caused a significant increase in the percentage of PCE. This gives 
evidence that CA at high doses (20 and 40 mg/kg) would be considered as a positive clastogen itself. 
CA significantly decreased the mitotic index compared with the negative control. In addition, high 
doses showed sharp decrease in mitotic index. Direct significant correlation coefficient was found 
between the ACI and the mitotic index. The data also were used for the simulation of a model to predict 
the ACI of doses with different relative timing to a treatment of the clastogen that were not conducted 
experimentally in the limit of experiment data range. 
 






Phenolic compounds have become increasingly impor-
tant in food industry as additive for flavor, taste, color and 
prevention of oxidative deterioration. In particular, many 
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food and medical scientists because of their anti-inflam-
matory, antimutagenic and anticarcinogenic properties 
and their ability to modulate some key enzyme functions 
(Francis, 1989; Chi-Tang et al., 1991). Hydroxycinnamic 
acid and its derivatives present a group of phenolic 
compound used in food that are derived from p-coumaric, 
caffeic, ferulic acid ((Chi-Tang et al., 1991; Hermann, 
1989). They usually occur in various conjugated forms, 
more frequently esters and glycosides. Flavonoids 
consist mainly of catechins, proanthcyanins antho-
cyanins, flavones and flavonols. It has been estimated 
that human consuming high fruit and vegetable, diets 
ingest  up  to 1 g  of  these  compounds  daily  (Chi- Tang 




et al., 1992). 
 
 
Antimutagenic effects of phenolic compounds 
 
Many plant phenols including ferulic, caffeic, chlorogenic, 
ellagic acids, tannic acid, several hydroxylated anthrax-
quinone and CA derivatives inhibit the mutagenicity and 
cytotoxicity of benzo[a]pyrene and its carcinogenic 
metabolite (Alexander et al., 1982; Mou-Tuan et al., 
1985). Isoflavones fremontin and fremontone isolated 
from roots of Psorothamnus fremontii (Fabaceae) were 
found to be nontoxic to Salmonella typhimurium and were 
highly active in the inhibition of mutagenicity of ethyl 
methanesulfonate (EMS) at all concentrations tested 
(Manikumar et al., 1989). The Iioflavones genstein and 
diazedien were reported to have antimutagenic activity 
through their suppressive effect on umu gene expression 
of the SOS response in S. typhimurium TA1535/pSK1002 
against the mutagen 3-amino-1,4-dimethyl-5H-pyrido 
[4,3b]indole (Trp-P-1) which requires liver metabolizing 
enzymes (Mitsuo et al., 1999). Vanillin is able to inhibit 
mutation at the CD59 locus and modify toxicity in a 
mutagen-specific manner. Possible mechanisms to 
explain the action of vanillin include inhibition of a DNA 
repair process that leads to the death of mutants or 
enhancement of DNA repair pathways that provide 
protection from mutation, but create lethal DNA lesions 
during the repair process (Daniel et al., 2000). 
The antimutagenic effect of Cinnamomum cassia 
against two mutagens; benzo[a]pyrene (B[a]P) and 
Endoxan was examined using the Ames test, in vivo 
chromosomal aberration and micronucleus test. Changes 
in liver cytochrome P450 (Cyt P450), glutathione content 
(GSH), glutathione S-transferase (GST), glutathione 
reductase (GR) and glutathione peroxidase (GPX) were 
evaluated in pretreated animals. Pretreatment decreased 
Cyt P450 content but increased GSH content and the 
activity of glutathione-dependent antioxidant enzymes; 
GST, GR and GPX. The antimutagenic effect of C. cassia 
could be attributed to its modulatory effect on the 
xenobiotic bioactivation and detoxification processes 
(Sharma et al., 2001). The antigenotoxic effect of 
nordihydroguaiaretic acid (NDGA), a phenolic lignan, was 
studied against chlormadinone acetate (CMA) in mice 
bone-marrow cells. It reduced the sister chromatid 
exchanges and chromosomal aberrations induced by 
CMA. Earlier studies showed that CMA generates reac-
tive oxygen species which are responsible for genotoxic 
damage. The free radical-scavenging property of NDGA 
is responsible for the reduction of genotoxic damage 
induced by CMA in mice bone-marrow cells (Siddique et 
al., 2008). Curcumin has been reported to have antimu-
tagenic effect against sodium azide induced chromo-
somal aberrations in Allium cepa root meristem, but 
showed low levels of cytotoxicity indicated in reducing the 





groups. The antimutagenic activity of curcumin is effec-
tive at 5 µg/ml in A. cepa root meristem cells (Irulappan 
and Natarajan, 2007). Vannilic and CA were found to 
have antimutagenic activity against spontaneous muta-
tions in mammalian (human) cells (Audrey et al., 2007). 
A correlation was found between the anticlastogenic 
effect and the antioxidant activity of various flavonoids. 
This suggests that the effect of flavonoids may be 
attributed to the hydroxyl radical scavenging activity in a 
direct or an endogenous enzyme mediated manner 
(Kayoko et al., 1994; Wei, 1995). CA was reported to be 
antioxidant in lipid peroxidation and hydroxyl radicals in 
the NADPH (Árka et al., 2003). Some flavonoids, 
especially quercetin are strong antioxidants which raised 
the possibility that quercetin and its related substances 
might reduce risks of cancer, cardiovascular disease and 
stroke in human (Sampson et al., 2002). 
 
 
Anticlastogenic effect of polyphenols 
 
Polyphenols reduced significantly the frequency of micro-
nucleated cells among bone marrow cells and peripheral 
blood cells. They are effective in preventing DNA damage 
and one of the mechanisms of action might involve 
scavenging of active oxygen radicals (Yamagishi et al., 
2001). Phenolics of olive oil are the only substance that 
showed a significant anticlastogenic activity before and 
after x-ray irradiation treatments. They have free oxygen 
radicals and lipoperoxyradicals scavenging activities 
(Benavente et al., 2002). The flavonoids quercetin and its 
glucoside isoquercitrin, administered orally reduced the 
number of PCE mice bone marrow (Edenharder et al., 
2003). Citrus extract of (Citrus aurantium var. amara) 
significantly reduced the frequencies of PCE. The 
optimum dose for protection in mouse was 250 mg/kg to 
protect mice bone marrow from the side effects of γ-
irradiation with respect to the non-drug-treated irradiated 
control. Therefore, fruits and vegetables contain flavo-
noids that have protective effects under such stress 
conditions as irradiation (Hosseinimehr et al., 2003). 
 
 
Correlation of ACI of polyphenols with 
anticarcinogenic potential 
 
Curcumin has been reported as a signal transduction 
modulator and inhibitor of transcription factors such as 
NF- B. Curcumin increased the cytotoxicity in cultures of 
cells isolated from the bone marrow of a patient with non-
Hodgkin's lymphoma (NHL). Curcumin is characterized by 
low toxicity and was described to have a chemoprotective 
activity. Therefore, the level of reduced glutathione (GSH) 
was measured and a concentration-dependent increase 
of GSH levels was recorded in AR-230 and SKW-3 cells 
(concentration range 5 to 25 µM). Experiments with mice 
showed     significant   protection    against   chromosomal  




Table 1. Distribution of mice groups on treatments. 
 
Treatment 
Administration time of CA relative to Endoxan 
24 hB* 3 hB** Concurrent 3 hA** 24 hA* 
NC NC +     
NC  +    
NC   +   
PC PC +     
PC  +    
PC   +   
CA ¼ LD50 + + + + + 
1/8 LD50 + + + + + 
1/16 LD50 + + + + + 
1/32 LD50 + + + + + 
 
*24 h before or after concurrent treatment; **3 h before or after concurrent 
treatment.  




aberrations (clastogenic effect) and inhibition of mitosis in 
bone marrow cells. Curcumin alone caused reduction of 
the mitotic index. In addition, curcumin has protective and 
anticlastogenic activity by enhancing the scavenging of 
free radicals (Tzvetan et al., 2007). In this study, the 
focus was to study the administration time of one 
important member of flavonoids, CA, which is present in 
one of the famous natural spices namely “cinnamon” 
using micronucleus test to measure the anticlastogenic 
activity of Endoxan as well as its effect upon mitotic 
index. The obtained data were employed to develop a 
new index called ACI. The ACI simplify the analysis of 
anticlastogenic data and can be used to predict the ACI 
of the tested compound in a concentration range inclu-
ding some concentrations that have not been 
experimentally carried out. 
 
 




HPLC grade of CA was purchased from Sigma-Aldrich Company. 




Animals and doses 
 
Eight week old Swiss albino mice (Mus musculus, 2n = 40, 25 g per 
animal) were maintained under conventional laboratory conditions 
at room temperature for two weeks. Commercial pellet diet and tap 
water were provided during the experiment. CA was dissolved in 
DMSO at four different concentrations (50, 25, 12.5 and 6.25 mg 
per 10 ml DMSO) for preparations of 1/4 LD50 (40 mg/kg), 1/8 LD50 
(20 mg/kg), 1/16 LD50 (10 mg/kg) and 1/32 LD50 (5 mg/kg) stocks, 
respectively (http://msds.chem.ox.ac.uk/CI/cinnamic_acid.html). The 
four doses were administered by giving each animal 0.1 ml from the 
corresponding stock. Endoxan was dissolved in DMSO to make a 
stock giving 0.1 ml per mouse (0.4 mg/kg). The negative control 
group received 0.1 ml of DMSO. 
Treatments 
 
Experiment 1: Effect of administration time and dose of CA. 
 
This experiment was designed to estimate the administration time 
and dose of CA on the anticlastogenic activity of CA. Five 
administration times were chosen; 24 h before and after giving the 
Endoxan, 3 h before and after giving the Endoxan and the 
concurrent time with Endoxan. Seventy eight (78) mice were used 
in this experiment. They were randomly distributed into 26 groups 
(three animals per group). Three negative controls (NC) and three 
positive controls (PC) were used for the treatments at 24 h before 
and after, 3 h before and after and the concurrent time with 
Endoxan. Twenty (20) groups were used for the four levels of CA 
(¼ LD50, 1/8 LD50, 1/16 LD50, 1/32 LD50) and five times of CA 
administrations (Table 1). Distributions of mice into 26 groups over 




Experiment 2: CA effect on cell proliferation  
 
This experiment was designed to test the effect of CA on the cell 
proliferation rate (mitotic index). Forty five (45) mice were randomly 
distributed on 15 groups (3 animals each). Three NC groups were 
used for the three administration times of CA (35, 14 and 11 h). The 
remaining twelve groups were distributed on the four levels of CA 
(¼ LD50, 1/8 LD50, 1/16 LD50, 1/32 LD50) and the three adminis-
tration times (35, 14 and 11 h). Negative control group received 
equal volume of DMSO. Mice were killed after 11 h (1/2 mitotic 
cycle) of the last injection either with Endoxan or CA. 
 
 
Harvesting of bone marrow cells 
 
Animals were killed, lower abdomen, limbs were incised and femora 
were cleaned and separated from the hip joint. The ends of the 
femur were trimmed and a blunt needle was pushed to pierce the 
marrow cavity. Bone marrow was flushed out with isotonic solution 
(137 mM NaCl, 15 mM Na2HPO4, 2.5 KCl, 1 mM K2HPO4). The 
suspension was made up to 5 ml and centrifuged at 1200 rpm for 
10 min. The clear supernatant was discarded. Hypotonic solution 
(75 mM KCl) was added and the pellet was mixed thoroughly over a  




Table 2. Means (%) of PCE of CA dose and administration time combination 
and their interaction. 
 
Dose 
Administration time relative to Endoxan* 
Mean 
24 hB 3 hB Concurrent 3 hA 24 hA 
1/32 LD 50 29.33 15.66 13.33 14.93 18.43 18.34 
1/16 LD50 27.76 20.13 11.5 15.3 18.1 18.56 
1/8 LD50 39.6 43.1 44.63 43.67 39.03 42.00 
¼ LD50 40.77 43.1 46.33 43.47 43.1 43.35 
(-) Control 11.5 11.5 12.43 11.5 11.5 11.68 
(+) Control 38.06 38.23 38.43 38.43 38.03 38.24 
Mean 31.17 28.62 27.77 27.88 28.03  
 
*Data were transformed by angular transformation; LSD0.05 for timing of treatment 
relative to Endoxan means =1.5; LSD 0.05 for means of CA doses =1.4; LSD0.05 for 
the interaction of administration time and doses of CA =3.3; hrB:  hours before 




vortex and then incubated at 37°C for 20 min. The suspension was 
centrifuged at 1200 rpm for 10 min and the clear supernatant was 
discarded. Fixation solution (3 absolute methanol: 1 glacial acetic 
acid) was added drop by drop on the pellet with vortexing and left 
for 10 min. The fixation step was repeated twice and samples were 
kept at 4°C for 24 h (Schmid, 1975; Adler, 1988). 
 
 
Slides preparation and staining 
 
Cell suspensions were dropped by Pasteur pipette on clean 
sterilized slides (rinsed in methanol for 24 h) at a distance of 70 cm. 
Slides were stained in 4% Giemsa stain solution for 10 min (Adler, 
1988). Slides were photographed using Olympus microscope BH-2 
attached to automatic camera unit. 
 
 
Micronucleus (MN) scoring 
 
The MN in PCE cells were examined microscopically according to 
the method of Schmid (1975). The frequency of MN was counted 






The cell proliferation rate was estimated as the percentage of 
dividing cells to the total number of cells in stained slides. One 
thousand cells per mouse were examined (Brusick, 1987). 
 
 
Anticlastogenic index (ACI) 
 
A new index was introduced in this study, it is named anticlasto-
genic index (ACI). It is calculated for certain dose and duration of 
time for the tested compound used before or after treatment of the 
clastogen to test whether it has anticlasogenic or repair activity of a 
clastogenic compound. The ACI is defined as the percentage of 
decrease or increase of PCE induced by the clastogen used as 
positive control according to the following formula: 
 
%ACIx,y,z= 100 – {(% MN of tested compound) – (%MN of NC)/ (% 
MN of PC clastogen) – (%MN of NC)} X 100 
Where, x is the dose of the tested compound for anticlastogenicity 
(mg/kg); y is the duration of administration of the compound before 
or after treatment of the clastogen; z can be designated as one of 
two forms: before (B) or after (A). ACI = 0 when there is no 
anticlastogenic or clastogenic activity. ACI has positive values when 
the tested compound has anticlastogenic activity and has negative 
values when the tested compound has no ACI, but rather has 
clastogenic activity. In an experimental design where a positive 
clastogen is not used and the purpose is to estimate the natural ACI 
of a compound or natural product whether it has protective or 
repairing activity. The formula will be changed as follows: 
 
%ACIx,y,z= 100 – {(% MN of NC) – (%MN of tested compound)/ (% 
MN of PC)} X 100 
 
In this case (no positive clastogen), the ACI of the tested compound 
is designated protective and repairing. 
 
 
Statistical analysis and model simulation 
 
The data of PCE, ACI and MI for different doses and different 
administration time combinations were transformed by angular 
transformation. Data were analyzed as a factorial arrangement of 
dose of CA and its administration time relative to Endoxan in 
complete randomized design (CRD). Comparison between means 
was made via the least significant difference (LSD). Correlation 
between mitotic index and ACI was done using statistical analysis 
modules of Microsoft excel 2007 (Richard et al., 2001). Forecasting 
module of Microsoft excel 2007 was employed to conclude and /or 
predict the ACI for the untested doses of CA relative to Endoxan 
(Richard et al., 2001). 
 
 
RESULTS AND DISCUSSION 
 
Effect of CA on the percentage of PCE 
 
Lower dose of 1/32 LD50 and 1/16 LD50 of CA induced 
percentages of PCEs near to the average of negative 
control (11.68%). On the other hand, the high doses 1/8 
LD50 and 1/4 LD50 of CA induced percentages of PCE 
near to that of the positive control (38.24%) (Table 2).  








Administration time relative to Endoxan* 
Mean 
24 hB 3 hB Concurrent 3 hA 24 hA 
1/32 LD 50 39.84 72.9 84.77 75.07 65.67 67.65 
1/16 LD50 42.9 77.13 90 74.47 66.4 70.18 
1/8 LD50 -16.6 -21.07 -24.47 -23.6 -10.1 -19.17 
¼ LD50 -23.47 -28.57 -39.2 -29.73 -30.23 -30.24 
Mean 10.67 25.1 27.78 24.05 22.93  
 
∗Data were transformed by angular transformation; LSD 0.05 for timing of treatment 
relative to Endoxan means = 3.09; LSD 0.05 for means of CA doses = 3.45; LSD 0.05 
for the interaction of administration time and doses of CA = 6.91; hrB:  hours 




They resulted in very close overall averages of PCEs, 
18.34 and 18.56% at all various timings, respectively. 
The higher doses 1/8 LD50 and 1/4 LD50 of CA gave 
higher percentages of PCE, 42 and 43.35%, respectively 
at all administration times (Table 2). It seems CA itself 
induces PCEs at higher concentrations and has anti-
clasotgenic activity as well. Various administration times 
of CA did not show significant differences. There were no 
significant differences between the higher doses of CA, 
1/8 LD50 and 1/4 LD50. The negative control and the 
positive control groups were two separate groups using 
LSD of means. For this reason, it is clear that the best 
doses capable to decrease the percentage of PCE were 
1/32 LD50 and 1/16 LD50 of CA. Although, they scored low 
percentage of PCEs that made them differ significantly 
from that of the positive control and that of the higher 
doses, they differed significantly from the negative 
control. On the contrary, the higher doses of CA were 
rather toxic and their toxicity appeared as a combination 
of Endoxan toxicity because PCE percentages exceeded 
that of the positive control, lower doses and negative 
control significantly. Best interaction of administration 
time and dose of CA was obtained with dose 1/16 LD50 at 
concurrent administration, whereas worst interaction was 
obtained with dose 1/8 LD50 at concurrent administration. 
 
 
Effect of administration time of CA relative to 
Endoxan  
 
Table 2 shows that the administration time of CA to 
Endoxan had effect upon decreasing the percentages of 
PCE. At the concurrent administration of CA and Endo-
xan, the percentages of PCE were 13.33 and 11.5% for 
1/32 LD50 and 1/16 LD50 of CA, respectively. For the CA 
administration time, 3 h before and after Endoxan, the 
percentage of PCE was not significantly higher than that 
of concurrent administration time of CA to Endoxan as 
shown in Table 2.  
The case was different for the toxic doses 1/8 LD50 and 
1/4 LD50 of CA. The highest percentage of PCEs was 
scored at the concurrent treatment of CA and Endoxan. 
This may be due to their combined clastogenic activity in 
these treatments. They gave 44.63 and 46.33% PCE for 
1/8 LD50 and 1/4 LD50 of CA, respectively. The percen-
tages of PCE at 3 h before and after Endoxan treatment 
were less than that of 24 h before and after Endoxan 
(Table 2). Although, the percentage of PCEs were lower 
in a dose that corresponds to 1/16 LD50 of CA compared 
with that of 1/32 LD50 of CA, the decrease was not 
significant (Table 2). 
LSD means showed that the highest percentages of 
PCE were caused by doses 1/32 LD50 and 1/16 LD50 of 
CA at 24 h before Endoxan. It was clear giving 31.17 and 
28.03%, respectively. High percentage of PCE was found 
at 24 h before concurrent Endoxan compared with that of 
the 24 h of CA after Endoxan. This may be due to the 
mechanism of natural recovery and/or excretion of most 
CA from the body. 
 
 
ACI for the various doses of CA 
 
Lower doses of CA, 1/32 LD50 and 1/16 LD50, averaged 
an ACI of 67.65 and 70.18%, respectively for all 
administration times of Endoxan (Table 3, Figure 1). The 
higher doses, 1/8 LD50 and ¼ LD50, of CA showed a 
clastogenic index (negative ACI) rather than that of ACI 
with an average of -19.17 and -30.24% for all various 
administration time of CA. This revealed similar results to 
that have been obtained for PCEs (Table 2). Also, Figure 
1 reveals that both doses of 1/32 LD50 and 1/16 LD50 of 
CA showed high and close ACIs. On the other hand, the 
higher doses, 1/8 LD50 and 1/4 LD50, of CA showed close 
negative ACI, have clastogenic activity, rather than 
anticlastogenic activity. Table 3 and Figure 1 show that in 
the case of the lower doses of CA, 1/32 LD50 and 1/16 
LD50, the best administration time was the concurrent 
administration of CA and Endoxan. They gave the 
highest ACI of 84.77 and 90%, respectively. This 
significantly decreased at the 3 h before and after 
Endoxan as well as  at  24 h  before  and  after  Endoxan,  










respectively. On the other hand, higher doses (1/8 LD50, 
1/4 LD50) of CA, showed lower ACIs (-24.47 and -39.2%, 
respectively) when CA and Endoxan were given 
concurrently. It is clear that all results for higher doses 
are negative, meaning that they do not have ACI, but 
they have clastogenic activity (Table 3). 
It is easy to categorize the groups easily into anti-
clastogenic or clastogenic groups using LSD means 
(Table 3). No significant difference in ACI between the 
lower two doses of CA, but the two higher doses form a 
group with clastogenic index. LSD of means showed that 
the best administration time of CA is concurrently with 
Endoxan, while the worst at 24 h before Endoxan. This 
again may be due partially to the short half life of 
Endoxan. 
The use of the ACI introduced in this study gives the 
same accurate results and its interpretation. ACI showed 
parallel data to the data calculated of PCE percentages 
at lower doses of CA. The best relative administration 
time for CA is at concurrent time with Endoxan. This 
could be due to the short half life of Endoxan. Higher 
doses of CA were clastogenic rather than anticlastogenic 
and consequently have negative ACI values. The ACI 
makes it easier in understanding the index of the 
chemical compounds or extracts used since its value is a 
function of the percentage of the PCE in the clastogen 
treatment. Therefore, the deviation from this percentage, 
positive value of ACI to negative values means that the 
compound or extract has clastogenic potential. Overall, 
the high ACI values (Table 3) are associated with lower 
PCE (Table 2). This strongly supports the validity of the 
ACI and its use to measure the anticlastogenic activity of 
clastogens. 
The ACI for different doses  of  CA  administration  time  




Table 4. Means of MI* as affected by dose and duration of exposure to CA (cinnamic acid). 
 
Dose 
Duration of exposure to CA 
Mean 
35 h 14 h 11 h 
Negative control 20.3 20.83 20.57 20.57 
1/32 LD50 20.3 20 19.4 19.9 
1/16 LD50 19.4 19.4 19.4 19.4 
1/8 LD50 15.67 16.03 15.67 15.79 
1/4 LD50 15.3 14.2 14.57 14.69 
Mean 18.19 18.09 17.92  
 
∗Data were transformed by angular transformation; LSD 0.05 for means of CA doses = 0.29; LSD 0.05 
for means of duration of exposure to CA = 0.37; LSD 0.05 for the interaction between duration of 




relative to Endoxan were calculated according to the 
formula in materials and methods section. The highest 
ACI of CA as anticlastogenic was obtained when it was 
administered concurrently with Endoxan (Table 3). CA 
was less efficient as anticlastogenic when administered 
before Endoxan since administration after Endoxan 
showed higher ACI especially at 24 h after Endoxan. The 
interaction between the various doses of CA and their 
relative timing to CA also affects the values of ACI since 
the highest ACI values were obtained when CA and 
Endoxan were administered concurrently. The highest 
ACI was obtained at doses 1/16 LD50, 1/32 LD50 and the 
best administration time was the concurrent adminis-
tration giving mean of ACI 70.18 and 27.78, respectively 
(Table 3). For LSD means, there were a significant 
difference between the lower doses CA and that of 
negative control. It is clear that ACI differ significantly at 
higher doses at the various administration time compared 
with the positive control, negative control, as well as 
lower doses (Table 3). 
CA was reported to have antimutagenic activity and 
most of the phenolic classes have antioxidant activity 
(Mou-Tuan et al., 1985; Wei, 1995; Yoshioka et al., 1995; 
Sampson et al., 2002). The data are in accordance with 
the fact that CA has short half life of about 7 min (Jinhua 
et al., 1993; Castillo et al., 2000) and CA has anti-
mutagenic and antioxidant activity (Arka et al., 2003). 
Also, the ACI presented an evidence to emphasize that 
our results obtained as ACI are in parallel with anti-
carcinogen activity of other phenolic classes (Tzvetan et 
al., 2007). More work needs to be done on this 
compound to approve its anticarcinogenic activity and 




Effects of CA on mitotic index 
 
The effect of various doses of CA at different times rela-
tive to Endoxan on cell proliferation rate was estimated 
by mitotic index. Cell proliferation rate decreased at the 
two lower doses of CA, 1/32 LD50 and 1/16 LD50, with a 
slower rate compared with the sharp decrease in the 
mitotic index at the higher doses. There was a significant 
interaction between the dose and the duration of 
exposure of CA, but the only significant effect on the cell 
proliferation rate is due to the increase of the dose of CA 
(Table 4). This was caused by the increase of CA 
concentration. The results obtained gave an evidence to 
emphasize other results using other classes of phenolics 
informing that there is some cellular toxicity of phenolics 
decreasing the mitotic index significantly (Tzvetan et al., 
2007; Juliana et al., 2007; Irulappan and Natarajan, 
2007). The obtained data indicate that CA caused a 
significant decrease in mitotic index and this decrease 
has high slope at the higher doses, 1/8 and 1/4 LD50 of 
CA, but there were no significant effect of the duration of 
exposure of CA on the mitotic index (Table 4). LSD 
values showed that each dose group is independent from 
the other group, meaning that each group decreases the 
cell proliferation rate highly significant in a rate different 
from other groups. 
 
 
Correlation between ACI and mitotic index  
 
Positive correlation between ACI and MI was found which 
means that CA works at cellular activity not directly on 
chromosome structure. The correlation coefficient 
between the ACI and the mitotic index induced by CA 
treatment was highly significant (r = 0.95). CA decreases 
mitotic index significantly due to the increase of the dose 
of CA, but there were no significant effect of the duration 
of exposure to CA on the mitotic index (Table 4, Figure 
2). Some reports showed that the increase in ACI is 
accompanied by significant increase of mitotic index. 
Lower doses of CA (1/32 LD50 and 1/16 LD50) showed 
anticlastogenic activity. This may be one of the 
mechanisms made by CA to decrease the clastogenic 
potential through increasing the rate of cell proliferation to 
substitute aberrant cells. On the other hand, higher doses 
of CA with negative ACI are accompanied by decrease in 
mitotic index. This could be as a result of cellular toxicity 
which confirms that the higher doses of CA, 1/8 LD50 and  










1/4 LD50, showed cellular toxicity and caused significant 
decrease in mitotic index which increased CAI by 
replacing the aberrant cells. The obtained results agree 
with the results obtained by Tzvetan et al. (2007) on 
curcumin which showed correlation of ACI with its MI. 
 
 
Model simulation of ACI 
 
ACI with administration time of CA  
 
Dose 1/32 LD50 and 1/16 LD50: In this study, another 
way of analysis of clastogenic data was introduced which 
could make an efficient understanding of the anti-
clastogenic data. It is the model simulation of the ACI 
results. It is obvious of the results that the lower doses 
1/32 LD50, 1/16 LD50 of CA have significant ACI (Table 3). 
A model simulation of the ACI for administration time of 
CA relative to Endoxan that was not experimentally 
carried out, but lies in the timing range tested in the 
experiment.  
For dose 1/32 LD50 of CA, the derived equation from 
the curve of relative timing range from 24 h before 
treatment of CA to concurrent administration of CA and 
Endoxan was y = 1.7649X + 81.718; (y = ACI, x = relative 
timing of CA to Endoxan). The same equation for that of 
the relative timing range from 24 h after treatment of CA 
to concurrent administration of CA and Endoxan was y = 
-0.6675X + 81.208. From these equations, a graph was 
drawn for the relative timings that were not conducted 
and simulate their ACI on one hour intervals as shown in 
Figure 3. The closest two relative timings of treatment of 
CA to Endoxan, 1 h before and after, to the concurrent 
administration gave ACI of 80.54%, respectively. The 
second closest timings, 2 h before and after showed 
79.79   and  77.91%,  respectively.  These  two  points  of  











relative timings showed high ACI of CA which emphases 
the short term anticlastogenic activity of CA. For dose 
1/16 LD50 of CA, the derived equation from the curve of 
relative timing range from 24 h before treatment of CA to 
concurrent administration of CA and Endoxan was y = 
1.8395X + 86.555. The same equation for that of the 
relative timing range from 24 h after treatment of CA to 
concurrent administration of CA and Endoxan was y = -
0.7632x + 83.835. From these equations, a graph can be 
drawn for the relative timings that were not carried out. 
Simulation of their ACI on one hour intervals (Figure 4) 
showed that the closest two relative timings, 1 h before 
and after concurrent administration of CA to Endoxan 
showed ACI of 86.651 and 83.07%, respectively. The 
second closest two relative timings, 2 h before and after 
concurrent administration of CA to Endoxan showed ACI 
of 84.67 and 78.95%, respectively. These two points of 
relative timings showed high ACI of CA which emphases 
the short term anticlastogenic activity of AC (Figure 4). 
 
 
ACI with dose of CA 
 
Dose 1/32 LD50 to 1/8 LD50: Model simulation of the ACI 
for doses range from 1/32 LD50 (5 mg/kg) to 1/8 LD50 (20 
mg/kg) at a rate of 0.4 mg/kg was carried out. The 
expected function of ACI for doses 1/32 LD50 (5 mg/kg) 
and 1/16 LD50 (10 mg/kg) of CA was y = 0.448X+ 96.3 (y 
= ACI, X = dose of CA, mg/kg). The same function of ACI 
for dose 1/8 LD50 (20 mg/kg) of CA was y = -3.806X + 
36.13. As shown from the simulated model (Figure 5), it 
is clear that the different doses of a given anticlastogenic 
agent giving concurrently with the clastogenic agent 
improves the repair mechanism. The simulation model 
can be useful in informing us about a predicted ACI of 
using certain dose and this can be used for testing ACI of 
wide range of chemical compounds. 
The results obtained from this study clearly indicate 
that CA has anticlastogenic effect at lower doses, but has 
clastogenic activity at higher doses. This was confirmed 
with parallel positive ACI and negative ACI, respectively. 
Administration of CA was more efficient when it was 
concurrent with Endoxan. Also, application of CA before 
Endoxan was less efficient as anticlastogenic agent. This 
is far from concurrent administration before or after the 
less efficient of CA. This is in accordance with the fact 
that CA has short half life and dissipates fast from 
biological systems. The proposed ACI gives direct 
indication of the effect of anticlastogenic agent upon the 
repair system, since anticlastogenicity gives positive 
values of ACIs and clastogenicity gives negative ACIs. 
Mitotic index decreased with increasing ACI giving an 
evidence of the role of anticlastogen in enhancement of 
repair   system.  In  addition,  according  to  the  proposed  






Figure 4. Simulation of ACI of CA at dose 1/16 LD50 over 24 h before and after concurrent administration of CA and 






Figure 5. Simulation of ACI of CA and the various doses of CA (mg/kg) ranging from 1/32 LD50 to 1/8 LD50 based upon 0.4 




system previously mentioned that ACI can be predicted 
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